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Vg3 TCR cells develop in the fetal thymus and migrate
to the skin as dendritic epidermal T cells (DETC). Fetal
Vg3 thymocytes differentiate from immature heat stable
antigen (HSA)high cells to mature HSAlow cells and the
latter subset predominantly expresses IL-2 receptor b
chain (IL-2Rb). In this study, the role of IL-2Rb in the
development of Vg3 cells was determined in IL-2Rb-
deficient mice. There was a moderate reduction of mature
HSAlow Vg3 thymocytes in IL-2Rb-deficient mice. Small
numbers of Vg3 DETC were detected in the fetal skin of
IL-2Rb-deficient mice, but they were absent in newborn
and adult mice. These results suggest that IL-2Rb may
The effects of IL-2 are mediated through the specific cellsurface receptor (IL-2R) that is composed of threedistinct chains termed α, β, and γ (Taniguchi andMinami, 1993; The`ze et al, 1996). IL-2R β chain (IL-2Rβ) is shared by IL-15R (Grabstein et al, 1994; Giri
et al, 1994), whereas IL-2Rγ is utilized as a common subunit in IL-
4R, IL-7R, IL-9R, and IL-15R (Kondo et al, 1993; Noguchi et al,
1993; Russell et al, 1993; Miyazaki et al, 1994; Giri et al, 1994; Kimura
et al, 1995). Because both IL-2Rβ and IL-2Rγ are involved in signaling
by either IL-2 or IL-15 (Taniguchi and Minami, 1993; Giri et al, 1994;
The`ze et al, 1996), the biologic activity of IL-15 in vitro is similar to
that of IL-2 (Tagaya et al, 1996); however, the cellular distribution of
IL-15 in vivo is quite different from that of IL-2 (Tagaya et al, 1996)
and, recently, the specific α chain of IL-15R has been identified (Giri
et al, 1995).
Studies using gene-knockout mice deficient for IL-2 or individual
IL-2R chains have revealed the physiologic roles of the IL-2/IL-2R
system in vivo (reviewed by The`ze et al, 1996). Although IL-2 acts
in vitro as the principal cytokine inducing proliferation and activation
of T cells, IL-2-deficient (–/–) mice show normal or minimally
impaired immune responses in vivo (Ku¨ndig et al, 1993). In contrast,
IL-2Rβ–/– mice, in which both IL-2 and IL-15 signaling are inactiv-
ated, cannot elicit antigen-specific immune responses (Suzuki et al,
1995). Therefore, certain immunologic functions of IL-2 can be
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transduce the crucial signal for survival and/or expansion
of Vg3 cells in the fetal thymus and in the fetal skin. In
normal mice, IL-15 but not IL-2 mRNA was expressed
in the fetal epidermis and exogenous addition of low
concentration of IL-15 to fetal skin organ culture induced
proliferation of Vg3 DETC. The dependence of fetal Vg3
DETC on the expression of IL-2Rb and the presence of
IL-15 mRNA in the fetal epidermis imply an essential
role of IL-15 signaling through IL-2Rb in the selective
localization of this gd T cell subpopulation in the skin.
Key words: gd T cells/IL-15/T cell development. J Invest
Dermatol 110:961–965, 1998
compensated by IL-15 in vivo. IL-2–/–, IL-2Rα–/–, and IL-2Rβ–/–
mice, however, show the common phenotype involving deregulated
T cell activation and autoimmunity (Schorle et al, 1991; Willerford
et al, 1995; Suzuki et al, 1995), indicating the crucial role of IL-2 in
lymphoid homeostasis (The`ze et al, 1996). IL-15–/– mice have not
been reported and the physiologic roles of IL-15 in vivo remain to be
elucidated.
IL-2Rγ–/– mice show profound deficiencies in the lymphoid
development, characterized by highly reduced B cells and αβ T cells
and by an absence of γδ T cells and natural killer cells (DiSanto et al,
1995a; Cao et al, 1995). Impaired development of B cells and αβ T
cells in IL-2Rγ–/– mice may be related to the inactivation of the
signaling through IL-7R rather than IL-2/IL-15 signaling (reviewed
by DiSanto et al, 1995b; Leonard et al, 1995), because there is no gross
abnormality in the development of B cells or major αβ T cells in IL-
2–/–, IL-2Rα–/–, or IL-2Rβ–/– mice (Schorle et al, 1991; Willerford
et al, 1995; Suzuki et al, 1995). Recent evidence, however, demonstrated
that the signaling through IL-2Rβ is involved in the development of
other lymphocyte populations. Natural killer cells are severely dimin-
ished and natural killer cell activity cannot be induced in IL-2Rβ–/–
mice (Suzuki et al, 1997). The presence of functional natural killer
cells in IL-2–/– mice (Ku¨ndig et al, 1993) suggests that the development
of natural killer cells may partially depend on IL-15 signaling. Similarly,
IL-2Rβ–/– mice show a partial block during extrathymic development
of both αβ and γδ T cells in the gut (Suzuki et al, 1997).
The role of IL-2/IL-15 signaling in the thymic development of γδ
T cells has not been well documented. There were, however, several
studies suggesting the importance of IL-2Rβ-mediated signals in the
thymic development of Vγ3 TCR cells. Vγ3 cells develop only in the
fetal thymus and migrate to the skin as dendritic epidermal T cells
(DETC) before birth (Havran and Allison, 1988, 1990; Payer et al,
1991). Fetal Vγ3 thymocytes differentiate from immature heat stable
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antigen (HSA)high cells to mature HSAlow cells (Leclercq et al, 1993),
and the latter subset predominantly expresses IL-2Rβ (Kawai et al,
1995; Leclercq et al, 1995). It was reported that in utero treatment
with anti-IL-2Rβ monoclonal antibody (MoAb) results in complete
disappearance of Vγ3 DETC (Tanaka et al, 1992). Because IL-2–/–
mice have normal numbers of Vγ3 DETC (Schimpl et al, 1994), IL-
15 signaling may be crucial for the thymic development of this γδ T
cell subpopulation. This possibility is supported by the recent observa-
tion that exogenous addition of a low concentration of IL-15, but not
IL-2, to fetal thymic organ culture induces proliferation of Vγ3 cells
(Leclercq et al, 1996). Similarly, addition of anti-IL-2Rβ, but not anti-
IL-2Rα, MoAb to fetal thymic organ culture results in a selective
reduction of mature HSAlow Vγ3 cells (Leclercq et al, 1995). In fetal
thymic organ culture, however, the reduction of mature Vγ3 cells with
anti-IL-2Rβ MoAb is marginal and coaddition of anti-IL-2Rβ and
anti-IL-7 MoAb induces a severe reduction of this subset (Leclercq
et al, 1995). Therefore, redundancy may exist between the signaling
through IL-2Rβ and IL-7R in the thymic development of Vγ3 cells.
Recently, it was reported that IL-7R–/– mice have no Vγ3 DETC
(He and Malek, 1996; Maki et al, 1996a). Because IL-7R–/– mice
have a defect in TCRγ gene rearrangement (Maki et al, 1996b;
Cande´ias et al, 1997), the role of the signaling through IL-7R in the
later stages of the thymic development of Vγ3 cells cannot be
determined in these mice. Nevertheless, these previous observations
indicate that the complete disappearance of Vγ3 DETC by in utero
treatment with anti-IL-2Rβ MoAb cannot be solely accounted for by
the impaired development of Vγ3 thymocytes.
In this study, we examined the development of Vγ3 cells in IL-
2Rβ-deficient mice. Our results suggest that IL-2Rβ may transduce
the crucial signal for survival and/or expansion of Vγ3 cells not only
in the fetal thymus but also in the fetal skin, and that this signal may
be mediated by IL-15 rather than IL-2 in vivo.
MATERIALS AND METHODS
Mice IL-2Rβ-mutant mice were generated by gene targeting (Suzuki et al,
1995) and maintained on a C57BL/6 background. Wild-type (IL-2Rβ1/1),
heterozygous (1/–), and homozygous (–/–) mutant mice were identified by
polymerase chain reaction (PCR) of tail DNA (Suzuki et al, 1995). In some
experiments, C57BL/6 mice (Charles River, Atsugi, Japan) were also used. To
obtain timed pregnant mice, IL-2Rβ1/– mice were mated overnight and the
fetuses were removed at the indicated fetal day (FD) (plug date 5 FD0).
Cell preparations Fetal thymocyte suspensions were obtained by teasing the
thymic lobes with fine forceps and passing through a nylon mesh. Epidermal
cell suspensions were prepared from the entire skin (fetuses and newborn mice)
or from the ear skin (adult mice) by trypsinization as described (Tamaki et al,
1979) and viable cells were enriched by centrifugation through Lympholyte-M
(Cedarlane Laboratories, Hornby, ON, Canada) (Kawai et al, 1995).
Flow cytometry Cells (1–10 3 105) were resuspended in phosphate buffered
saline supplemented with 2% fetal calf serum, 0.1% NaN3, and 25 mM
ethylenediamine tetraacetic acid. After preincubation with anti-FcγII/III recep-
tor MoAb (clone 2.4G2, PharMingen, San Diego, CA) to avoid nonspecific
binding of MoAb, saturating amounts of fluoroscein isothiocyanate (FITC)- or
phycoerythrin-conjugated MoAb were added. The following MoAb as well as
isotype-matched control MoAb were purchased from PharMingen: FITC-
conjugated anti-Vγ3 (clone 536), PE-conjugated anti-IL-2Rβ (TM-β1), and
PE-conjugated anti-HSA (M1/69). Cells were incubated for 30 min at 4°C,
then washed, and 2 µg propidium iodide per ml was added just before analysis.
After gating on forward and side scatter and propidium iodide, 5000–20000
viable cells were analyzed for each sample using a FACScan flow cytometer
with the Lysis II program (Becton Dickinson, Mountain View, CA).
Immunofluorescence staining of epidermal sheets Epidermal sheets were
prepared by incubation in 0.5 M ammonium thiocyanate for 20 min at 37°C
(Juhlin and Shelley, 1977). Acetone-fixed epidermal sheets were stained with
FITC-conjugated anti-Vγ3 MoAb as described (Kawai et al, 1995). Vγ3 DETC
in a 0.0625 mm2 area were counted using a calibrated ocular grid. The density
of Vγ3 DETC was recorded as the mean cell number per mm2 of 10 random
fields per sheet.
Reverse-transcription polymerase chain reaction (RT-PCR) and South-
ern blotting Total RNA was extracted from the fetal thymus or from the
fetal epidermis of C57BL/6 mice using Micro RNA Isolation Kit (Stratagene,
La Jolla, CA). cDNA was synthesized with 1 µg RNA primed with random
hexamers using the First-Strand cDNA Synthesis Kit (Pharmacia Biotech,
Piscataway, NJ) in a 33 µl reaction mixture. PCR was performed in a total
volume of 50 µl containing 1 µl cDNA, 20 pmol each primer, 10 mM Tris-
HCl, 50 mM KCl, 1.5 mM MgCl2, 200 µM each dNTP, and 1.5 U Taq
polymerase (Takara Biomedicals, Otsu, Japan). PCR cycles were run for 30 s
at 94°C, 30 s at 60°C (for IL-2 and β-actin) or at 50°C (for IL-15), and 1 min
at 72°C. Before the first cycle, a denaturing step for 5 min at 94°C was
included, and after 35 cycles the extension was prolonged for 5 min at 72°C.
Primers and oligonucleotide probes for IL-2 and β-actin were purchased from
Clontech Laboratories (Palo Alto, CA). The following oligonucleotides were
used as the primers and probe for IL-15 (Anderson et al, 1995): sense 59-
GTGACTTTCATCCCAGTTGC-39, anti-sense 59-TCACATTCCTTGCA-
GCCAGA-39, probe 59-GCAATGAACTGCTTTCTCCTGGAATTGCAG-
39. For southern blotting, PCR products were separated on 1.5% agarose gels,
transferred to Nylon Membranes, positive charged (Boehringer Mannheim,
Mannheim, Germany), and hybridized with the probes that had been tailing
labeled with digoxigenin-11-dUTP (Boehringer Mannheim) according to the
manufacturer’s instructions. The hybridized probe was detected using DIG
Luminescent Detection Kit (Boehringer Mannheim).
Fetal skin organ culture Full thickness dorsal skin was excised from FD18
C57BL/6 mice and cut into small pieces (5 3 5 mm). The fetal skin was then
floated dermal side down on Iscove’s modified Dulbecco’s medium containing
10% fetal calf serum, 5 3 10–5 M 2-ME, and 1% antibiotic-antimycotic solution
(Gibco, Grand Island, NY) and cultured in 5% CO2 in humid air for 48 h at
37°C. Recombinant simian IL-15 (2 µg per ml) (Genzyme, Cambridge, MA),
20 µg anti-IL-2Rβ MoAb (clone TM-β1) per ml or control rat IgG2b, κ
MoAb (PharMingen) was added to the organ cultures as indicated. Epidermal
sheets were prepared and stained as described above.
RESULTS
Selective reduction of mature HSAlow Vg3 thymocytes in IL-
2Rb–/– mice Fetal Vγ3 thymocytes consist of immature HSAhigh
cells and mature HSAlow cells (Leclercq et al, 1993), and the thymic
maturation of Vγ3 cells is associated with expression of IL-2Rβ (Kawai
et al, 1995; Leclercq et al, 1995). To determine the role of IL-2Rβ in
the thymic development of Vγ3 cells, we examined fetal thymocytes
from IL-2Rβ–/– mice by flow cytometry. As shown in Fig 1 and
Table I, there was a moderate reduction of mature HSAlow Vγ3
Figure 1. Reduction of mature HSAlow Vg3 thymocytes in IL-2Rb–/–
mice. FD16 or FD17 thymocytes from IL-2Rβ 1/– or –/– mice were stained
with FITC-conjugated anti-Vγ3 and PE-conjugated anti-HSA MoAb. HSAhigh
and HSAlow Vγ3 cell subsets are gated and percentages of each population are
shown. The difference in the HSA intensities between FD16 and FD17
thymocytes reflects experimental variations. For each group, three mice were
analyzed independently and representative profiles are shown. Numerical data
are summarized in Table I.
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thymocytes in FD16 and FD17 IL-2Rβ–/– mice. Because immature
HSAhigh Vγ3 cells remained unaltered and reduced numbers of mature
HSAlow Vγ3 cells were present (Fig 1, Table I), the thymic maturation
of Vγ3 cells may not be directly affected in IL-2Rβ–/– mice. Rather,
these results suggest that the signaling through IL-2Rβ may be required
for survival and/or expansion of mature Vγ3 thymocytes.
Presence of Vg3 DETC in the fetal skin but not in the newborn
and adult skin of IL-2Rb–/– mice It should be noted that a
considerable number of mature HSAlow Vγ3 cells were present in the
FD17 thymus of IL-2Rβ–/– mice (Fig 1, Table I), at a stage where
Vγ3 cells have immigrated from the thymus to the skin (Payer et al,
1994). Therefore, it was of interest to determine whether Vγ3 DETC
were present in the fetal skin of IL-2Rβ–/– mice. As shown in Fig 2,
highly reduced but detectable numbers of Vγ3 DETC were present in
the FD18 epidermis of IL-2Rβ–/– mice. Vγ3 DETC, however, were
no longer observed in newborn (3 d old) or adult (5 wk old) IL-
2Rβ–/– mice (Fig 2). Essentially similar results were obtained by in
Figure 2. Presence of Vg3 DETC in fetal IL-2Rb–/– mice. Epidermal
cell suspensions from FD18, 3 d old (3 d), or 5 wk old (5 wk) IL-2Rβ1/
1 or –/– mice were stained with FITC-conjugated anti-Vγ3 and PE-conjugated
anti-IL-2Rβ MoAb. Quadrant settings were determined by staining with
isotype-matched control MoAb and percentages of each population are shown.
For each group, three mice were analyzed independently and representative
profiles are shown.
Table I. Reduced number of mature HSAlow Vg3 cells in the fetal thymus of IL-2Rb–/– mice
Cells per thymusa
Mice Total (3 10–5) Total Vγ3 cells HSAhigh Vγ3 cells HSAlow Vγ3 cells
FD16 1/– 9.3 6 1.5 23500 6 2300 10100 6 600 13400 6 1700
–/– 8.7 61.5 21500 6 6500 12800 6 4500 8700 6 2100b
FD17 1/– 16.7 6 7.6 36800 6 12200 6700 6 3100 30200 6 9100
–/– 20.0 67.5 27600 6 5800 8300 6 4900 19300 6 8700
aData are expressed as the mean cell number 6 SD (n 5 3) per thymus.
bThe reduction of HSAlow Vγ3 cells in FD16 IL-2Rβ–/– mice as compared with IL-2Rβ1/– mice is statistically significant (p , 0.05, Student’s t test).
situ immunofluorescence staining of epidermal sheets (data not shown).
These results suggest that IL-2Rβ may transduce the crucial signal for
survival of Vγ3 DETC in the fetal skin. Interestingly, the majority of
adult Vγ3 DETC in IL-2Rβ1/1 mice did not express IL-2Rβ,
whereas more than half of fetal Vγ3 DETC expressed IL-2Rβ (Fig 2).
Because Vγ3 DETC expand vigorously during the perinatal period
in vivo (Elbe et al, 1989; and data not shown), the downregulation of
IL-2Rβ by Vγ3 DETC after birth also implies an essential role of
signaling through IL-2Rβ in perinatal expansion of Vγ3 DETC.
Presence of IL-15 but not IL-2 mRNA in the fetal
epidermis Although previous studies demonstrated that both IL-2
and IL-15 are present in the fetal thymus (Dallman et al, 1991; Leclercq
et al, 1996), it is not known whether these cytokines are expressed in
the fetal skin. Therefore, we examined the expression of IL-2 and IL-
15 mRNA in the fetal thymus and in the fetal epidermis by RT-PCR
and Southern blotting. Both IL-2 and IL-15 mRNA were expressed
in the FD16 and FD17 thymi of normal C57BL/6 mice, whereas IL-
15 but not IL-2 mRNA was expressed in the FD18 epidermis (Fig 3).
Because only IL-15 and not IL-2 mRNA was present in the newborn
epidermis (data not shown), IL-15 may be the physiologic ligand for
IL-2Rβ expressed on Vγ3 DETC during the perinatal period in vivo.
Expansion of Vg3 DETC in fetal skin organ culture by exogenous
addition of IL-15 To determine whether IL-15 signaling promotes
survival and/or expansion of fetal Vγ3 DETC expressing IL-2Rβ, we
examined the effect of the exogenous addition of IL-15 on Vγ3 DETC
in fetal skin organ culture. Organ culture of FD18 skin sheets of
C57BL/6 mice for 48 h resulted in an approximate 2-fold expansion
Figure 3. Expression of IL-2 and IL-15 mRNA in the fetal thymus and
in the fetal epidermis. Total RNA was prepared from the FD16 or FD17
thymus, or the FD18 epidermis of C57BL/6 mice. Expression of IL-2, IL-15,
and β-actin mRNA were analyzed by RT-PCR and Southern blotting.
Representative data of two independent experiments are shown.
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Table II. Exogenous addition of IL-15 increases the number
of Vg3 DETC in fetal skin organ culturea
Added Vγ3 DETC per mm2b
Before culture 26 6 14
After 48 h culture None 59 6 6
IL-15 231 6 56
IL-15 1 control MoAb 268 6 22
IL-15 1 anti-IL-2Rβ MoAb 36 6 8
aFD18 skin sheets of C57BL/6 mice were organ cultured with or without 5 ng IL-15
per ml. Control MoAb or anti-IL-2Rβ MoAb (20 µg per ml) was added. Before or after
48 h organ culture, the number of Vγ3 DETC was determined by immunofluorescence
staining of epidermal sheets.
bData are expressed as the mean cell density 6 SEM of three experiments.
of Vγ3 DETC (Table II). The density of Vγ3 DETC after 48 h organ
culture was similar to that of neonatal (corresponding to FD20) mice
in vivo (data not shown). Exogenous addition of a low concentration
of IL-15 to the organ culture significantly augmented the proliferation
of Vγ3 DETC and this proliferation was specifically and completely
blocked with anti-IL-2Rβ MoAb (Table II). Therefore, the IL-2Rβ
can mediate IL-15-induced proliferation of Vγ3 DETC in the fetal skin.
DISCUSSION
In this study we demonstrated that mature HSAlow Vγ3 fetal thymocytes
that normally express IL-2Rβ (Kawai et al, 1995; Leclercq et al, 1995)
are reduced in IL-2Rβ–/– mice. It is unlikely that the reduction was
due to a maturational block, because the majority of immature Vγ3
thymocytes do not express IL-2Rβ in normal mice (Kawai et al, 1995;
Leclercq et al, 1995), and this subset did not accumulate in IL-2Rβ–/–
mice. Our results are consistent with the previous observation that
mature Vγ3 cells are selectively reduced by addition of anti-IL-2Rβ
MoAb to fetal thymic organ culture (Leclercq et al, 1995). Studies
have shown that mature Vγ3 thymocytes die by apoptosis in cell
suspension culture and this can be prevented by exogenous addition
of IL-2 (Leclercq et al, 1995). Therefore, the signaling through IL-
2Rβ may be required for survival of mature Vγ3 cells in the fetal
thymus. Although both IL-2 and IL-15 are expressed in the fetal
thymus (Dallman et al, 1991; Leclercq et al, 1996), IL-15 is more
potent than IL-2 in inducing expansion of Vγ3 thymocytes in fetal
thymic organ culture (Leclercq et al, 1996). Hyporesponsiveness to IL-
2 of mature Vγ3 thymocytes may be related to the lack of IL-2Rα
expression on the majority of this subset (Leclercq et al, 1995; and our
unpublished observation), because IL-2Rβ cannot directly bind IL-2
in mice (Chastagner et al, 1996). Thus, IL-15 may be the principal
cytokine promoting survival and/or expansion of mature Vγ3 thym-
ocytes.
As in fetal thymic organ culture in the presence of anti-IL-2Rβ
MoAb (Leclercq et al, 1995), mature Vγ3 thymocytes were not
eliminated completely in IL-2Rβ–/– mice. These observations indicate
that other cytokines could also support survival and expansion of
mature Vγ3 cells in the fetal thymus. In this context, it was reported
that IL-7 is involved in the maintenance of mature Vγ3 cells in fetal
thymic organ culture (Leclercq et al, 1995) and promotes survival and
expansion of Vγ3 DETC in vitro (Matsue et al, 1993). The signaling
through IL-2Rβ, however, should not be redundant for survival of
Vγ3 cells in vivo, because Vγ3 DETC were completely absent in adult
IL-2Rβ–/– mice. This observation is in agreement with the previous
study showing complete elimination of Vγ3 DETC by in utero treatment
with anti-IL-2Rβ MoAb (Tanaka et al, 1992), although the authors
did not define the site where the development of Vγ3 cells was
blocked. Our results suggest that IL-7 may promote survival and
expansion of Vγ3 cells in the fetal thymus, but cannot compensate for
the signaling through IL-2Rβ in the post-thymic development of
Vγ3 DETC.
We showed that highly reduced but detectable numbers of Vγ3
DETC are present in the fetal skin of IL-2Rβ–/– mice. The subsequent
disappearance of Vγ3 DETC after birth suggests that IL-2Rβ may
transduce the essential signal for maintenance of Vγ3 DETC. Because
we detected IL-15 but not IL-2 mRNA in the fetal skin, the physiologic
ligand for IL-2Rβ expressed on fetal Vγ3 DETC in vivo should be IL-
15. Although IL-15 mRNA expression does not always result in IL-
15 protein synthesis (Tagaya et al, 1996), production of IL-15 protein
was demonstrated in human epidermal keratinocytes (Mohamadzadeh
et al, 1995; Sorel et al, 1996). Therefore, survival and expansion of
Vγ3 DETC in the fetal skin may depend primarily on keratinocyte-
derived IL-15.
Although it is not known whether IL-15α is expressed on fetal Vγ3
DETC, more than half of fetal Vγ3 DETC expressed IL-2Rβ and low
levels of IL-2Rγ (our unpublished observation). Proliferation of Vγ3
DETC by exogenous addition of a low concentration of IL-15 to fetal
skin organ culture indicates that fetal Vγ3 DETC express a functional
IL-15R. Previous studies documented that both IL-2 and IL-15
promote the expansion of adult Vγ3 DETC in vitro (Nixon-Fulton
et al, 1986; Edelbaum et al, 1995). In fetal skin organ culture, exogenous
addition of IL-2 induced proliferation of Vγ3 DETC, although less
efficiently than IL-15 (our unpublished observation). Furthermore,
in vivo administration of IL-2 induces expansion of Vγ3 DETC
(Shibagaki et al, 1991). Therefore, IL-2 also promotes the expansion
of Vγ3 DETC in vivo, although we could not detect IL-2Rα expression
on Vγ3 DETC (our unpublished observation). Because low levels of
IL-2 mRNA were expressed in the adult epidermis (our unpublished
observation), IL-2 produced by Vγ3 DETC themselves (Kuziel et al,
1987) may play an essential role in the survival and expansion of Vγ3
DETC in the adult skin. Due to the lack of IL-2 in the fetal and
newborn skin, however, it is unlikely that IL-2 plays a critical role in
the development of Vγ3 DETC during the perinatal period. This
interpretation is supported by the observation that IL-2–/– mice have
normal numbers of Vγ3 DETC (Schimpl et al, 1994).
Surprisingly, transgenic mice overexpressing the IL-2Rβ were
reported to have no Vγ3 DETC (Suwa et al, 1995). Absence of Vγ3
DETC in these mice may be explained by hyperstimulation of Vγ3
cells through the transgenic IL-2Rβ leading to death by apoptosis.
Alternatively, the transgenic IL-2Rβ in these mice might compete for
other subunits or intracellular signaling molecules of the IL-2R/IL-
15R complex with endogenous IL-2R/IL-15R. Although the authors
demonstrated that the transgenic IL-2Rβ forms functional IL-2R in
thymocytes and spleen cells (Suwa et al, 1995), expression of individual
IL-2R chains is known to be regulated differently among various cell
types (Nakarai et al, 1994). Therefore, the transgenic IL-2Rβ might
form nonfunctional IL-2R/IL-15R in Vγ3 cells.
In adult mice, Vγ3 cells are found only in the skin (Havran et al,
1989). This selective localization of Vγ3 cells in the skin may be due
to expression of a skin-homing receptor on Vγ3 DETC precursors.
Such a receptor, however, has not been demonstrated thus far. Based
on the cytokine dependence of Vγ3 thymocytes, Leclercq et al (1995)
have recently raised an alternative possibility for the selective localization
of Vγ3 cells in the skin: Vγ3 DETC precursors may migrate to various
organs at random but they may die by apoptosis unless certain cytokines
that promote survival and expansion of Vγ3 DETC are present in the
environment. As this study demonstrated that fetal Vγ3 DETC depend
on IL-15 signaling through IL-2Rβ, the IL-15/IL-2Rβ system may
be involved in the selective localization of Vγ3 cells in the skin. Further
studies are needed to prove this possibility.
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